MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients

Autor:	Peter Pommerville, B.E. Persson, T. Kold Olesen, Marc Gittelman
Rok vydání:	2007
Předmět:	medicine.medical_specialty Gnrh receptor business.industry Urology medicine.disease chemistry.chemical_compound Prostate cancer Dose finding Endocrinology chemistry Internal medicine Gonadotrophin releasing hormone medicine Degarelix business
Zdroj:	Urology. 70:83-84
ISSN:	0090-4295
DOI:	10.1016/j.urology.2007.06.325
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::13adca8d4e83eee3cf38df7c44970a89 https://doi.org/10.1016/j.urology.2007.06.325 Zobrazit plný text záznamu Full Text from ScienceDirect